Loading…
Loading…
FDIT (Findit, Inc.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
FDIT does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for FDIT and 80,000+ other tickers.
See exactly how FDIT's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for FDIT and 80,000+ other tickers.
Findit, Inc. specializes in operating a comprehensive platform for managing social media content. Central to its offerings are Findit.com, an interactive search engine that enables users to submit URLs for indexing within its search results, and its complementary Findit mobile application. Beyond these core platform services, the company provides a wide array of digital marketing and development solutions. These encompass content creation and dissemination, professional web development, and strategic search engine optimization (SEO). Findit also orchestrates diverse social media and social…
The solution sets the standard for store fulfillment with associate-optimized work processes to source, pick, pack and deliver omnichannel orders from stores BOSTON , Dec. 30, 2024 /PRNewswire/ -- OneView Commerce , a leader in composable point of sale and omnichannel store solutions, today announced the launch of new features in their Omnichannel Order Fulfillment suite, including Batch Picking, Omni Returns and FindIt instant inventory location that combine to extend store personnel's ability to quickly and efficiently manage high-value omnichannel orders. Working with retail innovators, OneView has taken the lead and delivered into production an ultra-modern composable commerce platform that replaces legacy point of sale solutions and provides the agility needed to overcome competitive threats faced by brick-and-mortar retailers.
CHATTANOOGA, TN / ACCESSWIRE / March 14, 2024 / BioRegenx, Inc . (OTC PINK:FDIT) is proud to announce its participation as an exhibitor in the esteemed Roth Emerging Brand Showcase at the 36th Annual Roth Conference.
(This release corrects the release that posted earlier on March 13, 2024 to update the 1st paragraph grammatical update, 4th paragraph relating to the DocSun information, and update of company contact information) CHATTANOOGA, TN / ACCESSWIRE / March 14, 2024 / On March 8, 2024, the merger of BioRegenx , Inc. into Findit, Inc. (OTC PINK:FDIT) went effective along with the name change of the surviving entity to BioRegenx, Inc., by the state of Nevada and the SEC. Furthermore, BioRegenx is currently collaborating with FINRA to facilitate a name and symbol change.
CHATTANOOGA, TN / ACCESSWIRE / March 13, 2024 / On March 8, 2024, the merger of BioRegenx , Inc. into Atlanta GA/ Findit, Inc. (OTC PINK:FDIT) was cleared by the SEC on January 17, 2024 and went effective with the State of Nevada, along with the name change of the surviving entity to BioRegenx, Inc.. Furthermore, BioRegenx is currently collaborating with FINRA to facilitate a name and symbol change.
ATLANTA, GA / ACCESSWIRE / January 12, 2024 / FINDIT, Inc. (Ticker:FDIT) announced today the submission of its 14C Information Statement has been filed, revealing significant details about the pending merger with BioRegenx, Inc. FINDIT, Inc., the owner of Findit.com and the Findit App, has taken a pivotal step in its strategic development by disclosing comprehensive information pertaining to the impending merger with BioRegenx, Inc. The 14C filing elucidates key aspects of the agreement and the strategic direction FINDIT is moving towards with BioRegenx. This merger involves the integration of FINDIT, Inc. with BioRegenx, Inc., a company specializing in regenerative biotherapeutics and anti-aging research.